Day: January 23, 2026

Paris, January 23, 2026  Half-year report on the liquidity contract signed between AIR France-KLM and Rothschild Martin Maurel Under the liquidity contract entrusted by Air France-KLM to Rothschild Martin Maurel, as of December 31, 2025, the following assets were held in the liquidity account: 0 Securities€9,942,376 During the period from August 1, 2025 to December 31, 2025, a total of:  Number of transactions performed Number of shares traded Transactions amounts in €Purchase 19,770 6,715,379 80,103,544.01Sale 23,921 6,715,379 79,962,657.33It should be noted that upon its implementation on August 1, 2025, the following assets were held in the liquidity account: 0 Securities€10,000,000 Relations Investisseurs                                                         Michiel Klinkers                        Marouane Mami                                        ...

January 23, 2026 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**31 December 2025 43,203,225 49,128,937 49,076,688*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

PRESS RELEASECourbevoie – January 23, 2026 Bureau Veritas to acquire a leading Sustainability specialist for consumer products in Italy Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces the acquisition of SPIN360, a leading Italian consulting firm specialized in sustainable innovation and development across primary premium fashion and luxury brands.    This acquisition aligns with Bureau Veritas’ LEAP | 28 strategy to create new strongholds in the Consumer Product Services (CPS) industry, and to accelerate its growth in key markets such as Italy. The transaction will deliver on value creation opportunities, by combining SPIN360’s proprietary Life Cycle Assessment (LCA) tools and data-driven advisory services with Bureau Veritas’ certification and supply chain auditing expertise....

Stockholm, January 23, 2026 – Virtune AB (Publ) today announces an upcoming 10:1 share split of the Virtune Bitcoin Prime ETP (ticker: VIRBTCP). The share split will not affect the total value of investors’ holdings, and no action is required from investors. The share split is intended to facilitate trading in smaller denominations and thereby support improved trading liquidity and accessibility. Key information regarding the share split The share split will take effect at market open on February 2, 2026 in all markets where the product is available. Under the share split, each existing share of the Virtune Bitcoin Prime ETP will be split into ten (10) new shares. As a result, the NAV per share will be reduced by a factor of ten. The total value of each investor’s holding will remain unchanged, as the increase in the number of shares...

CEO Highlights Strategic Shift from Acquisition-Led Growth to Organic Expansion, Cost Discipline, and AI Infrastructure Initiatives to Drive Long-Term Value Celebration, FL, Jan. 23, 2026 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech enterprise, today announced preliminary unaudited revenue for fiscal year 2025, totaling an estimated $79 million. This represents an approximately 14% increase in revenue year-over-year, as compared to revenue for 2024 fiscal year. Joe La Rosa, CEO of La Rosa, commented, “In 2024, our growth strategy was largely acquisition-driven, as we focused on building scale and expanding our revenue base. In 2025, we deliberately shifted our focus toward organic growth, and we are particularly pleased that this year’s revenue increase was achieved...

RESEARCH TRIANGLE PARK, N.C., Jan. 23, 2026 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has completed its acquisition of Astria Therapeutics, Inc., initially announced on October 14, 2025. The transaction strengthens its position as a leader in hereditary angioedema (HAE) and enhances the company’s long-term growth trajectory. BioCryst adds navenibart, a late-stage, long-acting plasma kallikrein inhibitor currently in Phase 3 clinical development, to its HAE portfolio. The potential to be the first HAE therapy with every-three and every-six month dosing, combined with a high level of attack control, positions navenibart to significantly improve the treatment experience for HAE patients. With the addition of navenibart, BioCryst could offer both the leading oral therapy (ORLADEYO®) and...

FAT Brands’ Charitable Organization Fights Hunger for the Holiday Season LOS ANGELES, Jan. 23, 2026 (GLOBE NEWSWIRE) — The FAT Brands Foundation, the charitable arm of FAT (Fresh. Authentic. Tasty.) Brands Inc., a leading global franchising company that owns restaurant brands including Johnny Rockets, Fatburger, Round Table Pizza, and 15 other concepts, is pleased to announce it raised over $15,000 through its holiday giving campaign, helping Feeding America®, the nation’s leading hunger-relief organization, to provide meals to people experiencing food insecurity “As part of the restaurant community, food insecurity is a cause of great importance to us,” said Jessica Wiederhorn, President of FAT Brands Foundation. “Our network of supporters truly delivered—from the corporate team, vendors, franchisees, and more. The impact that...

ANCHORAGE, Alaska, Jan. 23, 2026 (GLOBE NEWSWIRE) — Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $12.4 million, or $0.55 per diluted share, in the fourth quarter of 2025, compared to $27.1 million, or $1.20 per diluted share, in the third quarter of 2025, and $10.9 million, or $0.49 per diluted share, in the fourth quarter a year ago. The decrease in the fourth quarter of 2025 compared to the third quarter of 2025 is primarily the result of the third quarter gain from the sale of certain assets by Pacific Wealth Advisors of $14.2 million. Additionally, in the fourth quarter of 2025 the Company had an increase in other operating expenses mostly due to performance-related increases in salaries and other personnel expense and marketing expense. The increase in marketing expense is...

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and live webcast to discuss its fourth quarter and full year 2025 financial results on Thursday, February 26th, 2026 at 8:30 a.m. Eastern Time and issue an earnings press release earlier that morning. The live webcast and a presentation related to the call will be accessible from the “Investors” section of Enovis’ website at www.enovis.com. Conference Call/Webcast Information Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link...